Find clinical documents

or

Document type:
RAG rating:question mark
Place:
Output type:
Medicine / Guideline Indication RAG rating Document type Place
Adalimumab Crohn's disease - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Adalimumab Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Alcohol Related n/a Clinical pathways Hertfordshire and West Essex ICB
Anal fissure Anal fissure n/a Prescribing pathway Hertfordshire and West Essex ICB
Bezlotoxumab Clostridium difficile Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Bile salts malabsorption Bile salts malabsorption Amber initiation Decision document Hertfordshire and West Essex ICB
Biologic and Biosimilar Medicines Where indicated n/a Patient information Hertfordshire and West Essex ICB
Botulinum toxin type A Focal spasticity, Hemi-facial spasm, Blepharospasm, Cervical dystonia, Frey’s syndrome, Chronic anal fissure, Dysphagia, Hirschsprung’s disease, Overactive bladder,Masseteric hypertrophy and temporomandibular disorders Red Prescribing guideline Hertfordshire and West Essex ICB
Budesonide - rectal (Budenofalk) Ulcerative colitis n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Budesonide (Jorveza) Inducing remission of eosinophilic oesophagitis Red NICE technology appraisal Hertfordshire and West Essex ICB
Cholecystectomy n/a Clinical policy Hertfordshire and West Essex ICB
Colesevelam 2nd line Diarrhoea associated with bile acid malabsorption Amber initiation n/a Hertfordshire and West Essex ICB
Colestyramine 1st line Diarrhoea associated with bile acid malabsorption Amber initiation n/a Hertfordshire and West Essex ICB
Crohn's disease Crohn's disease - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Darvadstrocel Complex perianal fistulas in Crohn’s disease Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Diltiazem ointment 3rd line Anal fissures Green n/a Hertfordshire and West Essex ICB
Dupilumab Eosinophilic oesophagitis Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Etrasimod Ulcerative Colitis - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Faecal Immunochemical Test (FIT) process pathway for suspected Lower GI Cancer n/a Clinical pathways Hertfordshire and West Essex ICB
Filgotinib Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Glyceryl trinitrate ointment 2nd line Anal fissures Green n/a Hertfordshire and West Essex ICB
Golimumab Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Inflammatory Bowel Disease (IBD) n/a Clinical pathways East and North Hertfordshire
Infliximab IV Crohn's disease - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Infliximab IV Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Infliximab IV biosimilar Diarrhoea or colitis associated with Immune Checkpoint Inhibitor therapy Red Decision document Hertfordshire and West Essex ICB
Laxido Constipation Green n/a Hertfordshire and West Essex ICB
Liver Function Test (LFT) n/a Clinical pathways Hertfordshire and West Essex ICB
Mesalazine - Octasa preferred 1st choice Inflammatory bowel disease Green n/a Hertfordshire and West Essex ICB
Mesalazine -Mezavant Inflammatory bowel disease Double Red n/a Hertfordshire and West Essex ICB
Methylnaltrexone bromide Opioid induced bowel dysfunction Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Methylnaltrexone bromide Constipation - opioid induced Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Mirikizumab Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Naldemedine Constipation - opioid induced Green NICE technology appraisal Hertfordshire and West Essex ICB
Naloxegol Constipation - opioid induced Green NICE technology appraisal Hertfordshire and West Essex ICB
Non-Alcoholic Fatty Liver Disease (NAFLD) n/a Clinical pathways East and North Hertfordshire
Obeticholic acid Primary biliary cholangitis (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Opioid Induced Constipation Opioid Induced Constipation n/a Prescribing pathway Hertfordshire and West Essex ICB
Ozanimod Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Paediatric Abdominal Pain n/a Clinical pathways Hertfordshire and West Essex ICB
Paediatric Constipation n/a Clinical pathways Hertfordshire and West Essex ICB
Paediatric Diarhoea and Vomitting n/a n/a Hertfordshire and West Essex ICB
Phosphate enema (Cleen) Constipation n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Prednisolone All indications - soluble tablet n/a Patient information Hertfordshire and West Essex ICB
Prednisolone enteric coated All indications Double Red n/a Hertfordshire and West Essex ICB
Probiotics Treatment or prevention of diarrhoea of any cause. Double Red Decision document Hertfordshire and West Essex ICB
Proton pump inhibitors - paediatric Gastro-protection Green Prescribing guideline Hertfordshire and West Essex ICB
Rifaximin Hepatic encephalopathy Amber initiation Decision document Hertfordshire and West Essex ICB
Risankizumab Crohn's disease - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Tofacitinib Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Ulcerative colitis Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Upadacitinib Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Upadacitnib Crohn's disease - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Ustekinumab Crohn's disease - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Ustekinumab Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Vedolizumab Crohn's disease - moderate to severe Red Prescribing pathway Hertfordshire and West Essex ICB
Vedolizumab Ulcerative colitis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB